|
1
|
Khan SA, Thomas HC, Davidson BR and
Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 366:1303–1314.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McLean L and Patel T: Racial and ethnic
variations in the epidemiology of intrahepatic cholangiocarcinoma
in the United States. Liver Int. 26:1047–1053. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khan SA, Emadossadaty S, Ladep NG, Thomas
HC, Elliott P, Taylor-Robinson SD and Toledano MB: Rising trends in
cholangiocarcinoma: Is the ICD classification system misleading us?
J Hepatol. 56:848–854. 2012. View Article : Google Scholar
|
|
4
|
Dhanasekaran R, Hemming AW, Zendejas I,
George T, Nelson DR, Soldevila-Pico C, Firpi RJ, Morelli G, Clark V
and Cabrera R: Treatment outcomes and prognostic factors of
intra-hepatic cholangiocarcinoma. Oncol Rep. 29:1259–1267. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aishima S and Oda Y: Pathogenesis and
classification of intra-hepatic cholangiocarcinoma: Different
characters of perihilar large duct type versus peripheral small
duct type. J Hepatobiliary Pancreat Sci. 22:94–100. 2015.
View Article : Google Scholar
|
|
6
|
Hwang S, Lee YJ, Song GW, Park KM, Kim KH,
Ahn CS, Moon DB and Lee SG: Prognostic impact of tumor growth type
on 7th AJCC staging system for intrahepatic cholangiocarcinoma: A
single-center experience of 659 cases. J Gastrointest Surg.
19:1291–1304. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tabrizian P, Jibara G, Hechtman JF,
Franssen B, Labow DM, Schwartz ME, Thung SN and Sarpel U: Outcomes
following resection of intrahepatic cholangiocarcinoma. HPB Oxf.
17:344–351. 2015. View Article : Google Scholar
|
|
8
|
Bao R, Shu Y, Wu X, Weng H, Ding Q, Cao Y,
Li M, Mu J, Wu W, Ding Q, et al: Oridonin induces apoptosis and
cell cycle arrest of gallbladder cancer cells via the mitochondrial
pathway. BMC Cancer. 14:2172014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiong J, Su T, Qu Z, Yang Q, Wang Y, Li J
and Zhou S: Triptolide has anticancer and chemosensitization
effects by down-regulating Akt activation through the MDM2/REST
pathway in human breast cancer. Oncotarget. 7:23933–23946. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li M, Zhang F, Wang X, Wu X, Zhang B,
Zhang N, Wu W, Wang Z, Weng H, Liu S, et al: Magnolol inhibits
growth of gallbladder cancer cells through the p53 pathway. Cancer
Sci. 106:1341–1350. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luszczki JJ, Andres-Mach M, Cisowski W,
Mazol I, Glowniak K and Czuczwar SJ: Osthole suppresses seizures in
the mouse maximal electroshock seizure model. Eur J Pharmacol.
607:107–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Q, Qin L, He W, Van Puyvelde L, Maes
D, Adams A, Zheng H and De Kimpe N: Coumarins from Cnidium monnieri
and their antiosteoporotic activity. Planta Med. 73:13–19. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Zhang W, Zhou L, Wang X and Lian Q:
Anti-inflammatory effect and mechanism of osthole in rats. Zhong
Yao Cai. 28:1002–1006. 2005.
|
|
14
|
Lin K, Gao Z, Shang B, Sui S and Fu Q:
Osthole suppresses the proliferation and accelerates the apoptosis
of human glioma cells via the upregulation of microRNA-16 and
downregulation of MMP-9. Mol Med Rep. 12:4592–4597. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Peng Y, Shi K, Wang H, Lu J, Li Y
and Ma C: Osthole inhibits proliferation of human breast cancer
cells by inducing cell cycle arrest and apoptosis. J Biomed Res.
29:132–138. 2015.PubMed/NCBI
|
|
16
|
Wen YC, Lee WJ, Tan P, Yang SF, Hsiao M,
Lee LM and Chien MH: By inhibiting snail signaling and miR-23a-3p
osthole suppresses the EMT-mediated metastatic ability in prostate
cancer. Oncotarget. 6:21120–21136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu W, Cao Y, Zhang Y, Li S, Gao J, Wang
XA, Mu J, Hu YP, Jiang L, Dong P, et al: Up-regulation of PKM2
promote malignancy and related to adverse prognostic risk factor in
human gallbladder cancer. Sci Rep. 6:263512016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wani ZA, Guru SK, Rao AV, Sharma S,
Mahajan G, Behl A, Kumar A, Sharma PR, Kamal A, Bhushan S, et al: A
novel quinazolinone chalcone derivative induces mitochondrial
dependent apoptosis and inhibits PI3K/Akt/mTOR signaling pathway in
human colon cancer HCT-116 cells. Food Chem Toxicol. 87:1–11. 2016.
View Article : Google Scholar
|
|
19
|
Lu DY, Chang CS, Yeh WL, Tang CH, Cheung
CW, Leung YM, Liu JF and Wong KL: The novel phloroglucinol
derivative BFP induces apoptosis of glioma cancer through reactive
oxygen species and endoplasmic reticulum stress pathways.
Phytomedicine. 19:1093–1100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsai CF, Yeh WL, Huang SM, Tan TW and Lu
DY: Wogonin induces reactive oxygen species production and cell
apoptosis in human glioma cancer cells. Int J Mol Sci.
13:9877–9892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Jiang G, Yao F, He Y, Liang G,
Zhang Y, Hu B, Wu Y, Li Y and Liu H: Growth inhibition and
apoptosis induced by osthole, a natural coumarin, in hepatocellular
carcinoma. PLoS One. 7:e37865. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding D, Wei S, Song Y, Li L, Du G, Zhan H
and Cao Y: Osthole exhibits anticancer property in rat glioma cells
through inhibiting PI3K/Akt and MAPK signaling pathways. Cell
Physiol Biochem. 32:1751–1760. 2013. View Article : Google Scholar
|
|
23
|
Liu LY, Huang WJ, Lin RJ, Lin SY and Liang
YC: N-Hydroxycinnamide derivatives of osthole presenting
genotoxicity and cytotoxicity against human colon adenocarcinoma
cells in vitro and in vivo. Chem Res Toxicol. 26:1683–1691. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang HY, Hsu YF, Chiu PT, Ho SJ, Wang CH,
Chi CC, Huang YH, Lee CF, Li YS, Ou G, et al: Anticancer activity
of an osthole derivative, NBM-T-BMX-OS01: Targeting vascular
endothelial growth factor receptor signaling and angiogenesis. PLoS
One. 8:e815922013. View Article : Google Scholar
|
|
25
|
Häcker G: The morphology of apoptosis.
Cell Tissue Res. 301:5–17. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang J, Lu ML, Dai HL, Zhang SP, Wang HX
and Wei N: Esculetin, a coumarin derivative, exerts in vitro and in
vivo antiproliferative activity against hepatocellular carcinoma by
initiating a mitochondrial-dependent apoptosis pathway. Braz J Med
Biol Res. 48:245–253. 2015. View Article : Google Scholar :
|
|
28
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shrivastav A and Murphy L: Interactions of
PI3K/Akt/mTOR and estrogen receptor signaling in breast cancer.
Breast Cancer Manag. 1:235–249. 2012. View Article : Google Scholar
|
|
30
|
Shi L, Wang L and Wang X: Osteopontin
induces epithelial-to-mesenchymal transitions in human lung cancer
cells via PI3K/Akt and MEK/Erk1/2 signaling pathways. Chest.
149:A332. 2016. View Article : Google Scholar
|
|
31
|
Riquelme I, Tapia O, Leal P, Sandoval A,
Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM,
et al: miR-101-2, miR-125b-2 and miR-451a act as potential tumor
suppressors in gastric cancer through regulation of the
PI3K/AKT/mTOR pathway. Cell Oncol (Dordr). 39:23–33. 2016.
View Article : Google Scholar
|
|
32
|
Xu X, Zhang Y, Qu D, Jiang T and Li S:
Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells
by modulating PI3K/Akt pathway. J Exp Clin Cancer Res. 30:332011.
View Article : Google Scholar : PubMed/NCBI
|
